Volta VX1 decision support software reproduces expert-physician electrogram (EGM) analysis that can assist physicians in the real-time identification of specific abnormal electrograms in a persistent atrial fibrillation (AF) population
News | Cardiovascular Surgery
Volta Medical’s AI Based solution for Patients in Atrial Fibrillation Achieves Robust Validation in First Peer-Reviewed Publication

September 7, 2022 — Nuwellis, Inc., a commercial-stage company focused on transforming the lives of people with fluid ...

Home September 07, 2022
Home
Graphical abstract During COVID19 total lockdown in 2020 in France, a significant reduction in vascular stiffness, recorded by home smart scales, was observed.© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society o f Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any me
News | Coronavirus (COVID-19)
Strict COVID Lockdowns in France Improved Cardiovascular Health

September 7, 2022 — A new paper in European Heart Journal - Digital Health, published by Oxford University Press ...

Home September 07, 2022
Home
Societies outline recommendations for hardware and software, training, competency, cross-specialty and collaboration
News | SPECT-CT
New ASNC-led Guideline Details How to Use CT in Hybrid Nuclear-CT Cardiac Imaging

September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...

Home September 07, 2022
Home
Prespecified meta-analysis of DELIVER and EMPEROR-Preserved presented in a Hot Line Session at ESC Congress 2022
News | Pharmaceuticals
Meta-Analysis Strengthens Evidence for SGLT2 Inhibitors in Patients With Heart Failure

September 6, 2022 — An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and ...

Home September 06, 2022
Home
Stopping statin treatment early could substantially reduce lifetime protection against heart disease since a large share of the benefit occurs later in life
News | Pharmaceuticals
Study Highlights Lifelong Benefits of Statin Therapy

September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease ...

Home September 06, 2022
Home
Smokers have weaker hearts than non-smokers, according to research
News | Stroke
Smoking is Even More Damaging to the Heart Than Previously Thought

September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 ...

Home September 06, 2022
Home
Research presented at ESC Congress 2022 supports a causal relationship between air pollution and heart attacks since smokers, who already inhale smoke, were unaffected by dirty air.
News | Stroke
Air Pollution is Associated with Heart Attacks in Non-Smokers

September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and ...

Home September 06, 2022
Home
BOX trial presented in a Hot Line Session at ESC Congress 2022
News | Sudden Cardiac Arrest
Restrictive Oxygenation in Post Cardiac Arrest Patients is Not Harmful

September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac ...

Home September 02, 2022
Home
DELIVER trial presented in a Hot Line Session at ESC Congress 2022
News | Heart Failure
Dapagliflozin Benefits Patients with Mildly Reduced and Preserved Ejection Fraction

September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...

Home September 02, 2022
Home
ADVOR trial presented in a Hot Line Session at ESC Congress 2022
News | Heart Failure
Acetazolamide Improves Decongestion in Patients with Acute Decompensated Heart Failure

September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients ...

Home September 02, 2022
Home
DANCAVAS trial presented in a Hot Line Session at ESC Congress 2022
News | Cardiac Imaging
Cardiovascular Screening May Reduce Risk of Death and Cardiovascular Disease

September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including ...

Home September 02, 2022
Home
DANFLU-1 trial presented in a Hot Line Session at ESC Congress 2022
News | Cardiac Imaging
Innovative Randomized Trial Hints at Mortality Benefits with High-Dose Influenza Vaccines

September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...

Home September 02, 2022
Home
Figure: EchoNet-RCT trial design
News | Artificial Intelligence
Artificial Intelligence Assessment of Heart Function is Superior to Sonographer Assessment

September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by ...

Home September 02, 2022
Home
REVIVED-BCIS2 trial presented in a Hot Line Session today at ESC Congress 2022
News | Heart Failure
Coronary Stenting Does Not Benefit Patients with Severe Left Ventricular Dysfunction

September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ...

Home September 02, 2022
Home
More than 30,271 health professionals from 174 countries attended this year’s event, which covered the entire field of cardiovascular medicine at ESC22
News | ESC
Best of ESC Congress 2022

September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...

Home September 01, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now